title: Recommendations for the implementation of Neoral C(2) monitoring in clinical practice.
authors.affiliation: University of Toronto, Toronto General Hospital, 621 University Ave., Toronto, Ontario M5G 2C4, Canada.
authors.forename: Edward
authors.initials: E
authors.lastname: Cole
authors.forename: Karsten
authors.initials: K
authors.lastname: Midtvedt
authors.forename: Atholl
authors.initials: A
authors.lastname: Johnston
authors.forename: James
authors.initials: J
authors.lastname: Pattison
authors.forename: Catherine
authors.initials: C
authors.lastname: O'Grady
mesh_terms: D000553:Ambulatory Care; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D016903:Drug Monitoring; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D016030:Kidney Transplantation; D016031:Liver Transplantation; D010865:Pilot Projects
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine